Sophocles H Voineskos1, Anne F Klassen1, Stefan J Cano1, Andrea L Pusic1, Christopher J Gibbons1. 1. From the Division of Plastic Surgery, Department of Surgery, and the Department of Pediatrics, McMaster University; Modus Outcomes; and the Division of Plastic and Reconstructive Surgery, Department of Surgery, and the Patient-Reported Outcomes, Value & Experience Center, Brigham and Women's Hospital.
Abstract
BACKGROUND: The reconstruction module of the BREAST-Q patient-reported outcome measure is frequently used by investigators and in clinical practice. A minimal important difference establishes the smallest change in outcome measure score that patients perceive to be important. To enhance interpretability of the BREAST-Q reconstruction module, the authors determined minimal important difference estimates using distribution-based methods. METHODS: An analysis of prospectively collected data from 3052 Mastectomy Reconstruction Outcomes Consortium patients was performed. The authors used distribution-based methods to investigate the minimal important difference for the entire patient sample and three clinically relevant groups. The authors used both 0.2 SD units (effect size) and the standardized response mean value of 0.2 as distribution-based criteria. Clinical experience was used to guide and assess appropriateness of results. RESULTS: A total of 3052 patients had BREAST-Q data available for analysis. The average age and body mass index were 49.5 and 26.8, respectively. The minimal important difference estimates for each domain were 4 (Satisfaction with Breasts), 4 (Psychosocial Well-being), 3 (Physical Well-being), and 4 (Sexual Well-being). The minimal important difference estimates for each domain were similar when compared within the three clinically relevant groups. CONCLUSIONS: The authors propose that a minimal important difference score of 4 points on the transformed 0 to 100 scale is clinically useful when assessing an individual patient's outcome using the reconstruction module of the BREAST-Q. When designing research studies, investigators should use the minimal important difference estimate for their domain of interest when calculating sample size. The authors acknowledge that distribution-based minimal important differences are estimates and may vary based on patient population and context.
BACKGROUND: The reconstruction module of the BREAST-Q patient-reported outcome measure is frequently used by investigators and in clinical practice. A minimal important difference establishes the smallest change in outcome measure score that patients perceive to be important. To enhance interpretability of the BREAST-Q reconstruction module, the authors determined minimal important difference estimates using distribution-based methods. METHODS: An analysis of prospectively collected data from 3052 Mastectomy Reconstruction Outcomes Consortium patients was performed. The authors used distribution-based methods to investigate the minimal important difference for the entire patient sample and three clinically relevant groups. The authors used both 0.2 SD units (effect size) and the standardized response mean value of 0.2 as distribution-based criteria. Clinical experience was used to guide and assess appropriateness of results. RESULTS: A total of 3052 patients had BREAST-Q data available for analysis. The average age and body mass index were 49.5 and 26.8, respectively. The minimal important difference estimates for each domain were 4 (Satisfaction with Breasts), 4 (Psychosocial Well-being), 3 (Physical Well-being), and 4 (Sexual Well-being). The minimal important difference estimates for each domain were similar when compared within the three clinically relevant groups. CONCLUSIONS: The authors propose that a minimal important difference score of 4 points on the transformed 0 to 100 scale is clinically useful when assessing an individual patient's outcome using the reconstruction module of the BREAST-Q. When designing research studies, investigators should use the minimal important difference estimate for their domain of interest when calculating sample size. The authors acknowledge that distribution-based minimal important differences are estimates and may vary based on patient population and context.
Authors: David W Lim; Helene Retrouvey; Isabel Kerrebijn; Kate Butler; Anne C O'Neill; Tulin D Cil; Toni Zhong; Stefan O P Hofer; David R McCready; Kelly A Metcalfe Journal: Ann Surg Oncol Date: 2021-04-05 Impact factor: 5.344
Authors: Meghana G Shamsunder; Thais O Polanco; Colleen M McCarthy; Robert J Allen; Evan Matros; Michelle Coriddi; Babak J Mehrara; Andrea Pusic; Jonas A Nelson Journal: Plast Reconstr Surg Date: 2021-12-01 Impact factor: 4.730
Authors: Lucy J van Hensbergen; Inge J Veldhuizen; Erica H Lee; Saskia Houterman; Tjinta Brinkhuizen; René R W J van der Hulst; Maarten M Hoogbergen Journal: Psychooncology Date: 2021-09-14 Impact factor: 3.955
Authors: Abbas M Hassan; Huan T Nguyen; Joseph P Corkum; Jun Liu; Sahil K Kapur; Carrie K Chu; Nina Tamirisa; Anaeze C Offodile Journal: Ann Surg Oncol Date: 2022-09-09 Impact factor: 4.339
Authors: Joshua Vorstenbosch; Colleen M McCarthy; Meghana G Shamsunder; Thais O Polanco; Stefan Dabic; Itay Wiser; Evan Matros; Joseph Dayan; Joseph J Disa; Andrea L Pusic; Michele R Cavalli; Elizabeth Encarnacion; Meghan Lee; Babak J Mehrara; Jonas A Nelson Journal: Plast Reconstr Surg Date: 2021-11-01 Impact factor: 5.169
Authors: Tanvee Singh; Lakshmi Goparaju; Aviram M Giladi; Oluseyi Aliu; David H Song; Kenneth L Fan Journal: Plast Reconstr Surg Glob Open Date: 2021-02-22
Authors: Jonas A Nelson; Thais O Polanco; Meghana G Shamsunder; Michelle Coriddi; Evan Matros; Madeleine E V Hicks; Joseph J Disa; Babak J Mehrara; Robert J Allen; Joseph H Dayan; Anoushka Afonso Journal: Ann Surg Oncol Date: 2021-05-06 Impact factor: 4.339
Authors: Jonas A Nelson; Meghana G Shamsunder; Joshua Vorstenbosch; Thais O Polanco; Evan Matros; Michelle R Coriddi; Babak J Mehrara; Robert J Allen; Joseph H Dayan; Joseph J Disa Journal: Plast Reconstr Surg Date: 2022-04-01 Impact factor: 5.169